Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 90

Results For "CAS"

1859 News Found

Cigniti bags ‘Best IoT Healthcare Platform’ award in 2023
News | May 10, 2023

Cigniti bags ‘Best IoT Healthcare Platform’ award in 2023

The Awards recognizes standout digital health & medical technology products and companies


Baxter  to sell its BioPharma Solutions Business to Advent International and Warburg Pincus for US $4.25billion
News | May 09, 2023

Baxter to sell its BioPharma Solutions Business to Advent International and Warburg Pincus for US $4.25billion

Proposed divestiture of BioPharma Solutions (BPS) further streamlines Baxter’s strategic focus and represents an important milestone in its ongoing business transformation


Dr Bharati Pravin Pawar launches Phase-III of Thalassemia Bal Sewa Yojana
Policy | May 09, 2023

Dr Bharati Pravin Pawar launches Phase-III of Thalassemia Bal Sewa Yojana

Launches Thalassemia Bal Sewa Yojana portal and releases standard treatment guidelines for sickle cell anemia disease


PredOmix launches campaign for free cancer screening
Healthcare | May 05, 2023

PredOmix launches campaign for free cancer screening

PredOmix has developed a novel blood test that can detect about 32 cancers in both men and women with 98 percent accuracy


Nouscom reaches clinical phase II using ProBioGen’s AGE1.CR.pIX production platform
News | May 05, 2023

Nouscom reaches clinical phase II using ProBioGen’s AGE1.CR.pIX production platform

Nous-209 has been developed using the Nouscom's viral vector platform


Brain Cells are starved of energy when autophagy malfunctions: New Study
News | May 05, 2023

Brain Cells are starved of energy when autophagy malfunctions: New Study

The Research by Indian Fellow at the University has major implications for neurodegenerative disease treatments


Mandaviya reviews organ donation policy
Policy | May 04, 2023

Mandaviya reviews organ donation policy

Organ Transplants triple across the country; rise from 5000 (2013) to more than 15000 in 2022


USFDA Advisory Committee votes  n Lynparza plus Abiraterone and Prednisone  for prostate cancer
Drug Approval | May 03, 2023

USFDA Advisory Committee votes n Lynparza plus Abiraterone and Prednisone for prostate cancer

The committee voted that FDA should restrict use of LYNPARZA plus abi/pred to these BRCAm mCRPC patients


IMCD Colombia acquires pharma API distributor Allianz
Supply Chain | May 03, 2023

IMCD Colombia acquires pharma API distributor Allianz

Allianz is ISO 9001:2015 certified and INVIMA certified for storage, sampling, dispensation, and distribution of APIs to the Colombian market


Innocan Pharma announces expansion to Lithuania, Latvia & Estonia markets
News | May 02, 2023

Innocan Pharma announces expansion to Lithuania, Latvia & Estonia markets

UAB Medexy's first order under the Distribution Agreement is for over 5000 units of SHIR and RELIEF&GO products